Tissue and Serum Concentrations of Time‐Dependent Antibiotics in Infected Diabetic Foot Ulcers by Bolus or Continuous Administration: The Randomised DFIATIM Trial
Diabetes/Metabolism Research and Reviews · 2026-07 · 42 (5)
DOI: 10.1002/dmrr.70185 ↗At a glance
Randomisierte kontrollierte Studie in Diabetes/Metabolism Research and Reviews, published online on 2026-05-30. Written by Radka Jarošíková and 14 co-authors. Institution: Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. Major MEDLINE topics: Diabetic Foot, Anti-Bacterial Agents, Amoxicillin-Potassium Clavulanate Combination, Ceftazidime. 31 references. The full text is freely available (open access, CC BY 4.0). Funded by: Ministry of Health of the Czech Republic, National Institute for Research of Metabolic and Cardiovascular Diseases, Next Generation EU and by Charles University.
Topics: Diabetisches Fußsyndrom
Abstract (original language)
Aims
The clinical effectiveness of antibiotic (ATB) therapy in patients with infected diabetic foot ulcers (iDFUs) depends on achieving sufficient ATB concentrations in both serum and peripheral tissues. This study evaluated the availability and bactericidal activity of the time‐dependent ATBs—ceftazidime (CTZ) and amoxicillin/clavulanate (AMC) in serum and peripheral tissues by comparing bolus versus continuous administration.
Methods
Sixty patients with iDFUs were randomised into four subgroups according to ATB and administration method: CTZ bolus (CTZ bolus ), CTZ continuous infusion (CTZ continuous ), AMC bolus (AMC bolus ), and AMC continuous infusion (AMC continuous ). Once steady‐state concentrations were reached, microdialysis was used to assess ATB levels in tissue adjacent to the ulcer. Serum and tissue samples were collected over a 6‐h period. Bactericidal activity was assessed by peak concentrations (Cmax), area under the curve (AUC), and the proportion of time free drug concentrations remained above the minimum inhibitory concentration (fT > MIC). Target thresholds were fT > MIC ≥ 60% for CTZ and ≥ 50% for AMC.
Results
All patients achieved serum fT > MIC targets for CTZ and AMC in 100% of AMC bolus and 89% of AMC continuous . In tissue, target attainment was 60% (CTZ bolus ), 73% (CTZ continuous ), 79% (AMC bolus ), and 83% (AMC continuous ). Bolus administration led to rapid serum peaks (5 min) and delayed tissue peaks (30–60 min), with subsequent declines. Continuous infusion produced gradual concentration increases over time.
Conclusions
While all patients achieved serum fT > MIC targets for CTZ and AMC (100% for AMC bolus and 89% for AMC continuous ), target attainment in tissue was substantially lower. These findings suggest that although serum pharmacodynamic targets are reliably achieved, tissue exposure remains suboptimal.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- Department of Internal Medicine, Second Faculty of Medicine, Charles University, Prague, Czech Republic.
- Department of Clinical Pharmacy and Drug Information Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- Department of Social and Clinical Pharmacy, Faculty of Pharmacy, Charles University, Hradec Kralove, Czech Republic.
- Department of Hygiene, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
- Department of Pathophysiology, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
ORCID profiles: Radka Jarošíková, Petr Tůma, Michal Dubský, Chahrazed Mekadim
Funding
- Ministry of Health of the Czech Republic
- National Institute for Research of Metabolic and Cardiovascular Diseases
- Next Generation EU and by Charles University
Cite
APA
Jarošíková, R., Sojáková, D., Antalová, S., Tůma, P., Polák, J., Dubský, M., Němcová, A., Wosková, V., Beca, P., Modos, I., Mareš, J., Mrázek, J., Mekadim, C., Skružná, M., & Fejfarová, V. (2026). Tissue and Serum Concentrations of Time‐Dependent Antibiotics in Infected Diabetic Foot Ulcers by Bolus or Continuous Administration: The Randomised DFIATIM Trial. Diabetes/Metabolism Research and Reviews, 42(5). https://doi.org/10.1002/dmrr.70185
Vancouver
Jarošíková R, Sojáková D, Antalová S, Tůma P, Polák J, Dubský M, et al. Tissue and Serum Concentrations of Time‐Dependent Antibiotics in Infected Diabetic Foot Ulcers by Bolus or Continuous Administration: The Randomised DFIATIM Trial. Diabetes/Metabolism Research and Reviews. 2026;42(5). doi:10.1002/dmrr.70185
BibTeX
@article{Jarokov2026,
author = {Jarošíková, Radka and Sojáková, Dominika and Antalová, Simona and Tůma, Petr and Polák, Jan and Dubský, Michal and Němcová, Andrea and Wosková, Veronika and Beca, Pavol and Modos, Istvan and Mareš, Jan and Mrázek, Jakub and Mekadim, Chahrazed and Skružná, Markéta and Fejfarová, Vladimíra},
title = {Tissue and Serum Concentrations of Time‐Dependent Antibiotics in Infected Diabetic Foot Ulcers by Bolus or Continuous Administration: The Randomised DFIATIM Trial},
journal = {Diabetes/Metabolism Research and Reviews},
year = {2026},
volume = {42},
number = {5},
doi = {10.1002/dmrr.70185}
}
EUVIMED